By: Michael Cavaretta On January 30, 2020 the World Health Organization declared that the novel coronavirus COVID-19 outbreak constituted a public health emergency of international concern. Infectious disease experts and public officials are urging several practical measures, such as hand washing, “social distancing” and self-quarantining when showing symptoms, to prevent a potentially catastrophic spike in …
Continue reading Force Majeure in Light of the Coronavirus Outbreak
Morse is pleased to announce that the Firm had a stand-out year for M&A deals in 2019, completing 22 transactions totaling just under $1 billion. The average deal size was $41 million. Additional deal data was reported on the Morse website, including an industry break-down which shows a strong year for healthcare/life sciences and technology …
By: Sean D. Detweiler When it comes to online marketplaces, there are numerous traps for the unwary, whether you are a startup or a multi-million dollar company. The “Better Business Bureau (BBB) has received thousands of complaints from people who have shopped for goods online and received counterfeit products instead of what they thought they ordered… …
Continue reading How to Prepare for Counterfeiters, Whether You Sell on Amazon.com or Not
On October 30th Corporate Attorney Michael Cavaretta of Morse gave a guest lecture to the Intro to Entrepreneurship class at Worcester State University on intellectual property and contract issues for startups. The class is geared toward entrepreneurs who are developing their own businesses, and is in line with Worcester State and its director of Entrepreneurship, …
By: Sean D. Detweiler Consumers continue to become increasingly more comfortable conducting business transactions of all types online, including filing trademark and patent applications, without the help of an attorney. At Morse, this has resulted in an increase of clients looking for help on a pending trademark or patent application previously initiated using an online …
Continue reading The Trademark Company, LegalZoom & Other Online Services
The Radio Entrepreneurs, a show that provides advice, information and connections for entrepreneurs, service providers and established companies, interviewed Morse trademark partner Stacey Friends. Stacey discusses trademark clearance, registration, and enforcement for large and small companies, as well as the recent USPTO rule change regarding specimens of use, based on the sudden influx of trademark applications from China. …
Continue reading Stacey Friends Interviewed by Radio Entrepreneurs
Morse is pleased to welcome Jill O. Edgar as a Patent Agent. Jill works with life science entities to assist with all aspects of their patent procurement, including prosecution of U.S. and foreign patents and rendering patentability and validity opinions. Jill is a Registered U.S. Patent Agent and has a broad range of interests within …
At the April 9th MassBio event Cross-Border Biotech Transactions: CFIUS and Other Risks, corporate partner John Hession will speak on the risks that early-stage biotech companies face when pursuing strategic alliances with foreign partners or investors. The discussion will center around the Committee on Foreign Investment in the United States' (CFIUS) expansion of its regulation …
Continue reading John Hession Speaking on CFIUS and Cross-Border Biotech Transactions
The MBBP Life Sciences group will host the panel event Show Me the Money: Bio Bucks, Royalties and Other Payment Structures in Strategic Alliances on Wednesday, April 3 in our Waltham office. Topics will include upfront license fees, technology access payments, milestone triggers, commercial due diligence fees, clinical trial milestones, royalty rates, and more. …
By: John Hession This week I attended a MassBio Forum Panel on Doing Business With China: Changing Regulatory Reforms and BD Opportunities in China. The panel members were Kate Haviland, Chief Business Officer at Blueprint Bio; Wei Zhao, Vice President at VP 6 Dimensions (Wuxi Ventures); and Kenneth Zhou, Partner at WilmerHale. The moderator was Ryan Roller, …
Continue reading MassBio Forum: Doing Business in China, Trade Friction or Pharma Fusion?
